DESIGN OF STRATEGIES FOR PERSONALIZED DOSE AND SCHEDULE IN THE CLINICAL DEVELOPMENT AND USE OF HSP90 INHIBITORS

$142,200FY2009Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators